NOKOMIS, Fla.--(BUSINESS WIRE)--As Rainbow Coral Corp. (OTCBB:RBCC) continues its due diligence on Nano3D Biosciences (n3D), it’s not just the early-stage biotech firm’s groundbreaking technology that has impressed RBCC—It’s also n3D’s revenues.
“Nano3D’s revolutionary Bio-Assembler system is already being commercially produced and sold,” said RBCC CEO Patrick Brown. “That’s rare for an early-stage company like n3D, and it makes the company very attractive. It fits our model target in this space—early-stage and close to or already commercial.